Company Snapshot
- Ticker
- IDXX
- Name
- IDXX
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 56403603200.000000
- Volume
- 460,689
- Avg Volume (3M)
- 496,410
IDXX
IDXX
Last update recent
704.20
-3.30
(-0.47%)
Market Cap
56403603200.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 4167411000.000000
- EPS
- 12.70
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 0.0%
- Net Income
- 1027425000.000000
- Net Margin
- 24.65%
- Payout Ratio
- 0.0%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 54.90
- Forward P/E
- None
- P/S
- 13.53
- P/B
- 36.13
- Beta
- None
- Debt / Equity
- 0.71
- Current Ratio
- 1.12
- Return on Equity
- 0.66%
- Return on Assets
- 0.30%
Technicals & Returns
- Distance vs 200 DMA
- 24.51%
- 200 DMA
- 565.59
- Distance vs 50 DMA
- 3.45%
- 50 DMA
- 680.73
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials Read more
- Name
- IDXX
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Jonathan J. Mazelsky
- Employees
- 11,000
- IPO Date
- 1991-06-21
- Phone
- 207 556 0300
- Address
- None
- Website
- https://www.idexx.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Latest News
Curated headlines from premium sources.
4 Medical Device Stocks to Buy for Healthy Returns in 2026
ISRG, PODD, BSX and IDXX lead medtech innovation with AI, robotics and diagnostics for growth in 2026.
Bamco Inc. NY Sells 27,157 Shares of IDEXX Laboratories, Inc. $IDXX
Bamco Inc. NY lessened its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 1.3% during the undefined quarter, according to its most recent filing with t…
Federated Hermes Inc. Has $15.79 Million Stock Position in IDEXX Laboratories, Inc. $IDXX
Federated Hermes Inc. lowered its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 7.3% in the second quarter, according to its most recent dis…
IDEXX Laboratories, Inc. $IDXX Shares Sold by Brant Point Investment Management LLC
Brant Point Investment Management LLC reduced its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 8.7% during the undefined quarter, according to its mo…
Brown Advisory Inc. Sells 10,408 Shares of IDEXX Laboratories, Inc. $IDXX
Brown Advisory Inc. lowered its stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 8.7% in the undefined quarter, according to the company in its most recent …
Edgestream Partners L.P. Has $1.48 Million Holdings in IDEXX Laboratories, Inc. $IDXX
Edgestream Partners L.P. cut its holdings in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 87.0% in the second quarter, according to its most recent Form 13F fili…